Intranasal COVID-19 vaccines: Is it a boon or bane?
- PMID: 34536600
- PMCID: PMC8443315
- DOI: 10.1016/j.ijsu.2021.106119
Intranasal COVID-19 vaccines: Is it a boon or bane?
Keywords: Advantages; COVID-19; Disadvantages; Immunity; Intranasal; SARS-CoV-2; Vaccines.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
Figures

References
-
- Zhao J., Zhao J., Mangalam A.K., Channappanavar R., Fett C., Meyerholz D.K., Agnihothram S., Baric R.S., David C.S., Perlman S. Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity. 2016;44(6):1379–1391. doi: 10.1016/j.immuni.2016.05.006. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous